Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Genomic Immune-phenotyping Profiles in Peripheral Blood Gene Signatures to Predict Risk of Kidney Transplant Rejection

NCT04727788 is registered in ClinicalTrials.gov with Verici Dx as lead sponsor.

NCT NCT04727788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04727788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Genomic Immune-phenotyping Profiles in Peripheral Blood Gene Signatures to Predict Risk of Kidney Transplant Rejection
Lead sponsor
Verici Dx
Phase
Observational
Overall status
Active, not recruiting
Start date
March 21, 2021
Completion date
December 31, 2025
Enrollment
550 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant rejection